Ims. Vanrijzingen et al., THE ACTH(4-9)ANALOG ORG-2766 AND RECOVERY AFTER BRAIN-DAMAGE IN ANIMAL-MODELS - A REVIEW, Behavioural brain research, 74(1-2), 1996, pp. 1-15
Treatment with adrenocorticotrophic hormone (ACTH), as well as with AC
TH fragments and analogues, can influence behaviour of animals and hum
ans. Furthermore it facilitates recovery of damaged peripheral nervous
tissue. The question whether ACTH/MSH peptides affect recovery proces
ses after injury to the central nervous system as well is addressed in
the present review. The effects of administration of the ACTH(4-9) an
alog ORG 2766 after brain lesions has been studied frequently. However
, the interpretation of the available data is confused by the variabil
ity of the results. Several factors can be identified which influence
the efficacy of the peptide: (i) not all behavioural tests are equally
suitable to reveal a peptide effect on behavioural recovery; (ii) the
affected brain area; (iii) whether cell bodies or terminals are affec
ted; (iv) the post-operative housing conditions; and (v) the onset and
duration of peptide administration. Two possible explanations of pept
ide efficacy on functional recovery are considered: first, the peptide
may accelerate spontaneously occurring recovery processes and second,
the peptide may induce compensatory mechanisms underlying functional
recovery without recuperation of the damaged neurons. These compensato
ry mechanisms seem to rely mainly on enhanced non-selective attention
by activation of limbic structures. It is as yet unknown to which rece
ptor system ORG 2766 binds; the analog lacks affinity for the known me
lanocortin (MC) receptors in brain, yet ORG 2766 is able to modulate t
he activity of endogenous opioids and the NMDA-receptor. A modulating
influence of the peptide on NMDA-receptor activity might indirectly ac
count for both enhanced attention-with ensuing behavioural recovery-an
d the acceleration of spontaneous recovery.